Table 3.1.
Indication | Appropriate Use Score (1–9) | |
---|---|---|
Creatinine Elevation and/or Hypertension | ||
34. | • Malignant hypertension (see Assumptions) | A (8) |
35. | • Resistant hypertension (see Assumptions) | A (8) |
36. | • Worsening blood pressure control in long-standing hypertensive patient | A (8) |
37. | • Hypertension in young person (age <35 years) | A (8) |
38. | • Unexplained size discrepancy between kidneys (>1.5 cm; in longest dimension) | A (7) |
39. | • Unknown cause of azotemia (eg, unexplained increase in creatinine) | A (7) |
40. | • Increased creatinine (>50% baseline or above normal levels) after the administration of ACE/ARBs | A (8) |
41. | • Acute renal failure with aortic dissection | A (8) |
42. | • Epigastric bruit | A (7) |
Heart Failure of Unknown Origin | ||
43. | • Refractory CHF | A (7) |
44. | • “Flash” pulmonary edema | A (8) |
ACE = angiotensin-converting enzyme inhibitor; ARB = angiotensin II receptor blocker; CHF = congestive heart failure.